Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma
Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant comp...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2004-11, Vol.10 (21), p.7427-7437 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7437 |
---|---|
container_issue | 21 |
container_start_page | 7427 |
container_title | Clinical cancer research |
container_volume | 10 |
creator | ARMSTRONG, Thomas PACKHAM, Graham MURPHY, Lindsay B BATEMAN, Adrian C CONTI, John A FINE, David R JOHNSON, Colin D BENYON, R. Christopher IREDALE, John P |
description | Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic
stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect
of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype.
Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic
relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures
of human PSCs, and type I collagen were investigated in a series of tissue culture models.
Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant
type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold.
Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up
to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1
cells in response to 5-fluorouracil (by regulating mcl-1).
Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote
the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host. |
doi_str_mv | 10.1158/1078-0432.CCR-03-0825 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67061025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17296509</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</originalsourceid><addsrcrecordid>eNqF0Mtu1DAUgGELUdELPALIG5C6SDk-ju3MsgotVCpihIa15XFOJkFJPNgZob49jmZQl13FUr7jy8_YewE3QqjqswBTFVBKvKnrnwXIAipUr9iFUMoUErV6ndf_zTm7TOk3gCgFlG_YeUayFAgXbLN52hN_4HUYBrejia9jGMNMic8d8e9u6HeTm2a-7mgK82JDy9du8pHc3Hv-5eBnN_DbJv_2Lvp-CqN7y85aNyR6d_pesV_3d5v6W_H44-tDfftYeCWquWgVokYyuJUrAtUqs8VtU6KXFaDxZWNQgjbgvJC-aYTUpZMOpUTTVqtGySv26bjvPoY_B0qzHfvkKb9konBINs9qAfgyFAZXWsEqQ3WEPoaUIrV2H_vRxScrwC7d7dLULk1t7m5B2qV7nvtwOuCwHal5njqFzuDjCbjk3dDGnLBPz06jlpVe3PXRdf2u-9tHsj5LipES5bzdcg8U1pRo5D8KjJfN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17296509</pqid></control><display><type>article</type><title>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><source>Alma/SFX Local Collection</source><creator>ARMSTRONG, Thomas ; PACKHAM, Graham ; MURPHY, Lindsay B ; BATEMAN, Adrian C ; CONTI, John A ; FINE, David R ; JOHNSON, Colin D ; BENYON, R. Christopher ; IREDALE, John P</creator><creatorcontrib>ARMSTRONG, Thomas ; PACKHAM, Graham ; MURPHY, Lindsay B ; BATEMAN, Adrian C ; CONTI, John A ; FINE, David R ; JOHNSON, Colin D ; BENYON, R. Christopher ; IREDALE, John P</creatorcontrib><description>Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic
stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect
of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype.
Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic
relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures
of human PSCs, and type I collagen were investigated in a series of tissue culture models.
Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant
type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold.
Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up
to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1
cells in response to 5-fluorouracil (by regulating mcl-1).
Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote
the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-03-0825</identifier><identifier>PMID: 15534120</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Antineoplastic agents ; Apoptosis ; Biological and medical sciences ; Blotting, Western ; Carcinoma, Pancreatic Ductal - metabolism ; Carcinoma, Pancreatic Ductal - pathology ; Cell Line, Tumor ; Cell Proliferation ; Cell Separation ; Collagen - chemistry ; Collagen - metabolism ; Collagen Type I - metabolism ; Collagen Type I - physiology ; Culture Media, Conditioned - pharmacology ; DNA - metabolism ; Dose-Response Relationship, Drug ; Enzyme-Linked Immunosorbent Assay ; Flow Cytometry ; Humans ; Immunohistochemistry ; Medical sciences ; Pancreas - cytology ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; Pharmacology. Drug treatments ; Phenotype ; Reverse Transcriptase Polymerase Chain Reaction ; RNA - metabolism ; Tissue Inhibitor of Metalloproteinase-1 - metabolism ; Tumors</subject><ispartof>Clinical cancer research, 2004-11, Vol.10 (21), p.7427-7437</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</citedby><cites>FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,3357,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16263860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15534120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ARMSTRONG, Thomas</creatorcontrib><creatorcontrib>PACKHAM, Graham</creatorcontrib><creatorcontrib>MURPHY, Lindsay B</creatorcontrib><creatorcontrib>BATEMAN, Adrian C</creatorcontrib><creatorcontrib>CONTI, John A</creatorcontrib><creatorcontrib>FINE, David R</creatorcontrib><creatorcontrib>JOHNSON, Colin D</creatorcontrib><creatorcontrib>BENYON, R. Christopher</creatorcontrib><creatorcontrib>IREDALE, John P</creatorcontrib><title>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic
stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect
of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype.
Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic
relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures
of human PSCs, and type I collagen were investigated in a series of tissue culture models.
Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant
type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold.
Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up
to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1
cells in response to 5-fluorouracil (by regulating mcl-1).
Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote
the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Antineoplastic agents</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Carcinoma, Pancreatic Ductal - metabolism</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cell Separation</subject><subject>Collagen - chemistry</subject><subject>Collagen - metabolism</subject><subject>Collagen Type I - metabolism</subject><subject>Collagen Type I - physiology</subject><subject>Culture Media, Conditioned - pharmacology</subject><subject>DNA - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Medical sciences</subject><subject>Pancreas - cytology</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - metabolism</subject><subject>Tumors</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0Mtu1DAUgGELUdELPALIG5C6SDk-ju3MsgotVCpihIa15XFOJkFJPNgZob49jmZQl13FUr7jy8_YewE3QqjqswBTFVBKvKnrnwXIAipUr9iFUMoUErV6ndf_zTm7TOk3gCgFlG_YeUayFAgXbLN52hN_4HUYBrejia9jGMNMic8d8e9u6HeTm2a-7mgK82JDy9du8pHc3Hv-5eBnN_DbJv_2Lvp-CqN7y85aNyR6d_pesV_3d5v6W_H44-tDfftYeCWquWgVokYyuJUrAtUqs8VtU6KXFaDxZWNQgjbgvJC-aYTUpZMOpUTTVqtGySv26bjvPoY_B0qzHfvkKb9konBINs9qAfgyFAZXWsEqQ3WEPoaUIrV2H_vRxScrwC7d7dLULk1t7m5B2qV7nvtwOuCwHal5njqFzuDjCbjk3dDGnLBPz06jlpVe3PXRdf2u-9tHsj5LipES5bzdcg8U1pRo5D8KjJfN</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>ARMSTRONG, Thomas</creator><creator>PACKHAM, Graham</creator><creator>MURPHY, Lindsay B</creator><creator>BATEMAN, Adrian C</creator><creator>CONTI, John A</creator><creator>FINE, David R</creator><creator>JOHNSON, Colin D</creator><creator>BENYON, R. Christopher</creator><creator>IREDALE, John P</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20041101</creationdate><title>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</title><author>ARMSTRONG, Thomas ; PACKHAM, Graham ; MURPHY, Lindsay B ; BATEMAN, Adrian C ; CONTI, John A ; FINE, David R ; JOHNSON, Colin D ; BENYON, R. Christopher ; IREDALE, John P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Antineoplastic agents</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Carcinoma, Pancreatic Ductal - metabolism</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cell Separation</topic><topic>Collagen - chemistry</topic><topic>Collagen - metabolism</topic><topic>Collagen Type I - metabolism</topic><topic>Collagen Type I - physiology</topic><topic>Culture Media, Conditioned - pharmacology</topic><topic>DNA - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Medical sciences</topic><topic>Pancreas - cytology</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ARMSTRONG, Thomas</creatorcontrib><creatorcontrib>PACKHAM, Graham</creatorcontrib><creatorcontrib>MURPHY, Lindsay B</creatorcontrib><creatorcontrib>BATEMAN, Adrian C</creatorcontrib><creatorcontrib>CONTI, John A</creatorcontrib><creatorcontrib>FINE, David R</creatorcontrib><creatorcontrib>JOHNSON, Colin D</creatorcontrib><creatorcontrib>BENYON, R. Christopher</creatorcontrib><creatorcontrib>IREDALE, John P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ARMSTRONG, Thomas</au><au>PACKHAM, Graham</au><au>MURPHY, Lindsay B</au><au>BATEMAN, Adrian C</au><au>CONTI, John A</au><au>FINE, David R</au><au>JOHNSON, Colin D</au><au>BENYON, R. Christopher</au><au>IREDALE, John P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>10</volume><issue>21</issue><spage>7427</spage><epage>7437</epage><pages>7427-7437</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic
stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect
of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype.
Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic
relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures
of human PSCs, and type I collagen were investigated in a series of tissue culture models.
Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant
type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold.
Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up
to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1
cells in response to 5-fluorouracil (by regulating mcl-1).
Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote
the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15534120</pmid><doi>10.1158/1078-0432.CCR-03-0825</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2004-11, Vol.10 (21), p.7427-7437 |
issn | 1078-0432 1557-3265 |
language | eng |
recordid | cdi_proquest_miscellaneous_67061025 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research; Alma/SFX Local Collection |
subjects | Adenocarcinoma - metabolism Adenocarcinoma - pathology Antineoplastic agents Apoptosis Biological and medical sciences Blotting, Western Carcinoma, Pancreatic Ductal - metabolism Carcinoma, Pancreatic Ductal - pathology Cell Line, Tumor Cell Proliferation Cell Separation Collagen - chemistry Collagen - metabolism Collagen Type I - metabolism Collagen Type I - physiology Culture Media, Conditioned - pharmacology DNA - metabolism Dose-Response Relationship, Drug Enzyme-Linked Immunosorbent Assay Flow Cytometry Humans Immunohistochemistry Medical sciences Pancreas - cytology Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Pharmacology. Drug treatments Phenotype Reverse Transcriptase Polymerase Chain Reaction RNA - metabolism Tissue Inhibitor of Metalloproteinase-1 - metabolism Tumors |
title | Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T18%3A01%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20I%20Collagen%20Promotes%20the%20Malignant%20Phenotype%20of%20Pancreatic%20Ductal%20Adenocarcinoma&rft.jtitle=Clinical%20cancer%20research&rft.au=ARMSTRONG,%20Thomas&rft.date=2004-11-01&rft.volume=10&rft.issue=21&rft.spage=7427&rft.epage=7437&rft.pages=7427-7437&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-03-0825&rft_dat=%3Cproquest_cross%3E17296509%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17296509&rft_id=info:pmid/15534120&rfr_iscdi=true |